Pathway Studio, ChemEffect Module Deployed at M.D. Anderson to Investigate Mechanism of Drug Action

Ariadne announces that The University of Texas M. D. Anderson Cancer Center has upgraded their Pathway Studio® installation with Ariadne’s ChemEffect® drug-centric module. This module, along with Pathway Studio’s protein-centric data, is assisting M. D. Anderson’s research pipeline aimed at enhancing therapeutic utility of the enzyme-drug L-Asparaginase (L-ASP).

Source: Ariadne Genomics